Moreover, the frequency of terminally differentiated NK cells (CD56dimCD16+CD57+), which had a potent cytotoxic function and low replication capacity, was increased in the bone marrow of novo AML patients and correlated with a lower survival rate [67]. The gene discussed is B3GAT1; the disease is acute myeloid leukemia.